Patents by Inventor Osamu Kotera

Osamu Kotera has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Imidazolidine compounds
    Publication number: 20040127507
    Abstract: Disclosed are novel compounds and a method of treating inflammatory diseases.
    Type: Application
    Filed: December 9, 2003
    Publication date: July 1, 2004
    Applicants: Millennium Pharmaceuticals, Inc., Kyowa Hakko Kogyo Co., Ltd.
    Inventors: Etsuo Ohshima, Hiroki Sone, Osamu Kotera, Jay R. Luly, Gregory J. LaRosa
  • Imidazolidine compounds
    Publication number: 20040122026
    Abstract: Disclosed are novel compounds and a method of treating inflammatory diseases.
    Type: Application
    Filed: December 9, 2003
    Publication date: June 24, 2004
    Applicants: Millennium Pharmaceuticals, Inc., Kyowa Hakko Kogyo Co., Ltd.
    Inventors: Etsuo Ohshima, Hiroki Sone, Osamu Kotera, Jay R. Luly, Gregory J. LaRosa
  • Imidazolidine compounds
    Publication number: 20030225288
    Abstract: Disclosed are novel compounds and a method of treating inflammatory diseases.
    Type: Application
    Filed: April 12, 2002
    Publication date: December 4, 2003
    Applicants: Millennium Pharmaceuticals, Inc., Kyowa Hakko Kogyo Co., Ltd.
    Inventors: Etsuo Ohshima, Hiroki Sone, Osamu Kotera, Jay R. Luly, Gregory J. LaRosa
  • Chemokine receptor antagonists and methods of use therefor
    Publication number: 20030045516
    Abstract: Disclosed are novel compounds and a method of treating a disease associated with aberrant leukocyte recruitment and/or activation.
    Type: Application
    Filed: August 13, 2002
    Publication date: March 6, 2003
    Applicant: Millennium Pharmaceuticals, Inc.
    Inventors: Jay R. Luly, Yoshisuke Nakasato, Etsuo Ohshima, Hiroki Sone, Osamu Kotera, Geraldine C. B. Harriman
  • Chemokine receptor antagonists and methods of use therefor
    Patent number: 6509346
    Abstract: Disclosed are novel compounds and a method of treating a disease associated with aberrant leukocyte recruitment and/or activation. The method comprises administering to a subject in need an effective amount of a compound represented by: and physiologically acceptable salts thereof.
    Type: Grant
    Filed: July 28, 1999
    Date of Patent: January 21, 2003
    Assignees: Millennium Pharmaceuticals, Inc., Kyowa Hakko Kogyo Co., Ltd.
    Inventors: Jay R. Luly, Yoshisuke Nakasato, Etsuo Ohshima, Hiroki Sone, Osamu Kotera, Geraldine C. B. Harriman
  • Chemokine receptor antagonists and methods of use therefor
    Patent number: 6503926
    Abstract: Disclosed are novel compounds and a method of treating a disease associated with aberrant leukocyte recruitment and/or activation. The method comprises administering to a subject in need an effective amount of a compound represented by: and physiologically acceptable salts thereof.
    Type: Grant
    Filed: July 28, 1999
    Date of Patent: January 7, 2003
    Assignees: Millennium Pharmaceuticals, Inc., Kyowa Hakko Kogyo Co., Ltd.
    Inventors: Jay R. Luly, Yoshisuke Nakasato, Etsuo Ohshima, Hiroki Sone, Osamu Kotera, Geraldine C. B. Harriman
  • Imidazolidine compounds
    Patent number: 6495569
    Abstract: Disclosed are novel compounds and a method of treating inflammatory diseases. The method comprises administering to an individual in need an effective amount of an imidazolidine compound represented by Structural Formula (I): and physiologically or pharmaceutically acceptable salts thereof.
    Type: Grant
    Filed: April 19, 2001
    Date of Patent: December 17, 2002
    Assignees: Millennium Pharmaceuticals, Inc., Kyowa Hakko Kogyo Co., Ltd.
    Inventors: Etsuo Ohshima, Hiroki Sone, Osamu Kotera, Rie Komatsu, Gregory J. LaRosa, Jay R. Luly
  • Chemokine receptor anagonists and methods of use therefor
    Publication number: 20020169155
    Abstract: Disclosed are novel compounds and a method of treating a disease associated with aberrant leukocyte recruitment and/or activation.
    Type: Application
    Filed: November 21, 2001
    Publication date: November 14, 2002
    Applicant: Millennium Pharmaceuticals, Inc.
    Inventors: Jay R. Luly, Yoshisuke Nakasato, Etsuo Ohshima, Hiroki Sone, Osamu Kotera, Geraldine C.B. Harriman, Kenneth G. Carson
  • CHEMOKINE RECEPTOR ANTAGONISTS AND METHODS OF USE THEREFOR
    Publication number: 20020161005
    Abstract: Disclosed are novel compounds and a method of treating a disease associated with aberrant leukocyte recruitment and/or activation.
    Type: Application
    Filed: July 28, 1999
    Publication date: October 31, 2002
    Inventors: JAY R. LULY, YOSHISUKE NAKASATO, ETSUO OHSHIMA, HIROKI SONE, OSAMU KOTERA, GERALDINE C. B. HARRIMAN
  • Imidazolidine compounds
    Patent number: 6469002
    Abstract: Disclosed are novel compounds and a method of treating inflammatory diseases. The method comprises administering to an individual in need an effective amount of an imidazolidine compound represented by Structural Formula (I): and physiologically or pharmaceutically acceptable salts thereof.
    Type: Grant
    Filed: April 19, 2001
    Date of Patent: October 22, 2002
    Assignees: Millennium Pharmaceuticals, Inc., Kyowa Hakko Kogyo Co., Ltd.
    Inventors: Etsuo Ohshima, Hiroki Sone, Osamu Kotera, Rie Komatsu, Gregory J. LaRosa, Jay R. Luly
  • CHEMOKINE RECEPTOR ANTAGONISTS AND METHODS OF USE THEREFOR
    Publication number: 20020119973
    Abstract: Disclosed are novel compounds and a method of treating a disease associated with aberrant leukocyte recruitment and/or activation.
    Type: Application
    Filed: July 28, 1999
    Publication date: August 29, 2002
    Inventors: JAY R. LULY, YOSHISUKE NAKASATO, ETSUO OHSHIMA, HIROKI SONE, OSAMU KOTERA, GERALDINE C.B. HARRIMAN